Global infant formula market is estimated to be valued at USD 81.42 Bn in 2024, exhibiting a compound annual growth rate (CAGR) of 10.3% from 2024 to 2031. Global infant formula market has been witnessing steady growth in the recent past few years. Infant formula refers to formulas manufactured for feeding babies and infants under 12 months of age. It is usually prepared for bottle-feeding or cup-feeding from powder (mixed with water) or liquid (ready-to-feed). It primarily composes of cow's milk that has been modified and supplemented with additional nutrients including vitamins, minerals and other ingredients. Various factors such as growing preference for packaged food, rising women workforce participation rate, increasing health awareness regarding infant nutrition and demand for organic/all-natural products are expected to drive the market growth.
Market Dynamics:
Global infant formula market growth is driven by rising working women population across both developed and developing nations. Rising demand for convenience foods due to increasing number of dual-income households has boosted the sales of packaged infant formula. Moreover, growing awareness among parents about the importance of essential nutrients in healthy baby development is driving the market growth. Increasing per capita disposable incomes in emerging economies has increased affordability of premium infant nutrition products. Furthermore, rising demand for goat milk formula and organic/all-natural variants generate opportunities for the market players.
Key Features of the Study:
- This report provides in-depth analysis of the global infant formula market, and provides market size (US$ Bn & KT) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global infant formula market based on the following parameters company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Kendamil USA, Nestle, USA, Arla Foods, Bobbie, Dana Dairy Group, Danone S.A., Abbott Nutrition, Mead Johnson Nutrition, The Kraft Heinz Company, Meiji Holdings Co. Ltd., Synutra International Inc., Pfizer Inc., Friesland Campina, Bubs Organic, LLC., Perrigo Company plc, Bellamy's Organic., Glanbia plc, Reckitt Benckiser Group PLC., and PT Kalbe Farma Tbk.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global infant formula market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global infant formula market.
Detailed Segmentation-
- By Ingredient:
- Cow’s milk based
- Soy Based
- Hypoallergenic
- Others (Lactose free, Goat’s milk, etc. )
- By Form:
- Powder forms
- Liquid concentrate forms
- Ready-to-feed forms
- By Distribution Channel:
- Supermarkets and Hypermarkets
- Convenience stores
- Online
- Others (Specialty stores, etc.)
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles:
- Kendamil USA
- Nestle, USA
- Arla Foods
- Bobbie
- Dana Dairy Group
- Danone S.A.
- Abbott Nutrition
- Mead Johnson Nutrition
- The Kraft Heinz Company
- Meiji Holdings Co. Ltd.
- Synutra International Inc.
- Pfizer Inc.
- Friesland Campina
- Bubs Organic, LLC.
- Perrigo Company plc
- Bellamy's Organic.
- Glanbia plc
- Reckitt Benckiser Group PLC.
- PT Kalbe Farma Tbk